Real-world experience at a Scottish university teaching hospital regarding the tolerability and persistence with topical Ciclosporin 0.1% (Ikervis) treatment in patients with dry eye disease.
作者信息
Hind Jennifer, Macdonald Elisabeth, Lockington David
机构信息
Tennent Institute of Ophthalmology, Gartnavel General Hospital, 1053 Great Western Road, Glasgow, G12 0YN, UK.
出版信息
Eye (Lond). 2019 Apr;33(4):685-686. doi: 10.1038/s41433-018-0289-7. Epub 2018 Nov 29.
Abstract
摘要
相似文献
1
Real-world experience at a Scottish university teaching hospital regarding the tolerability and persistence with topical Ciclosporin 0.1% (Ikervis) treatment in patients with dry eye disease.苏格兰一家大学教学医院关于0.1%环孢素局部用药（Ikervis）治疗干眼症患者的耐受性和持续性的真实世界经验。
Eye (Lond). 2019 Apr;33(4):685-686. doi: 10.1038/s41433-018-0289-7. Epub 2018 Nov 29.
2
One-Year Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in the Treatment of Severe Dry Eye Disease.0.1%环孢素A阳离子乳剂治疗重度干眼病的一年疗效与安全性
Eur J Ophthalmol. 2017 Nov 8;27(6):678-685. doi: 10.5301/ejo.5001002.
3
Keratitis in Dry Eye Disease and Topical Ciclosporin A.干眼疾病中的角膜炎与局部用环孢素A
Ocul Immunol Inflamm. 2017 Aug;25(4):577-586. doi: 10.1080/09273948.2016.1276933. Epub 2017 Feb 1.
4
Ciclosporin eye drops (Ikervis°) and dry eye syndrome.
Prescrire Int. 2017 Apr;26(181):96-97.
5
Evaluating the novel application of cyclosporine 0.1% in ocular surface disease.评估环孢素 0.1%在眼表疾病中的新应用。
Expert Opin Pharmacother. 2018 Jun;19(9):1027-1039. doi: 10.1080/14656566.2018.1479742. Epub 2018 May 30.
6
Topical ciclosporin in the treatment of ocular surface disorders.局部用环孢素治疗眼表疾病。
Br J Ophthalmol. 2005 Oct;89(10):1363-7. doi: 10.1136/bjo.2005.070888.
7
Cyclosporine 0.09% solution (Cequa) for dry eye Disease.用于干眼症的0.09%环孢素溶液（Cequa）
Med Lett Drugs Ther. 2019 Jul 29;61(1577):116-118.
8
When eyes get dry and what you can try. If artificial tears didn't work, anti-inflammatory cyclosporine drops may.当眼睛干涩时你可以尝试的方法。如果人工泪液不起作用，抗炎的环孢素滴眼液可能会有用。
Harv Health Lett. 2010 Oct;35(12):4-6.
9
Reversibility of dry eye deceleration after topical cyclosporine 0.05% withdrawal.局部应用环孢素 0.05%停药后干眼减速的可逆性。
J Ocul Pharmacol Ther. 2011 Dec;27(6):603-9. doi: 10.1089/jop.2011.0073. Epub 2011 Oct 14.
10
Topical cyclosporine for treatment of ocular surface disease.局部应用环孢素治疗眼表疾病。
Int Ophthalmol Clin. 2006 Fall;46(4):105-22. doi: 10.1097/01.iio.0000212135.77675.6a.
引用本文的文献
1
Reduced Ocular Surface Inflammation in SMILE Patients: The Beneficial Outcome of 0.1% Ciclosporin Cationic Emulsion Treatment.全飞秒激光小切口基质透镜切除术患者眼表炎症减轻：0.1%环孢素阳离子乳剂治疗的有益效果
Clin Ophthalmol. 2025 Aug 4;19:2565-2573. doi: 10.2147/OPTH.S536742. eCollection 2025.
2
Recent Achievements and Perspectives in Smart Nano-in-Micro Platforms for Ocular Disease Treatment.用于眼部疾病治疗的智能微纳平台的最新成果与展望
Int J Nanomedicine. 2025 Jun 17;20:7579-7612. doi: 10.2147/IJN.S518643. eCollection 2025.
3
Impact of cyclosporine A on the progression of ocular surface diseases: treatment efficacy and potential complications.环孢素A对眼表疾病进展的影响：治疗效果及潜在并发症
J Med Microbiol. 2025 Mar;74(3). doi: 10.1099/jmm.0.001978.
4
Real-world insights and outcomes related to ciclosporin A 0.1% cationic emulsion for the long-term treatment of dry eye disease in Germany: Country-level sub-analysis of the PERSPECTIVE study.关于环孢素 A 0.1%阳离子乳剂用于德国干眼症长期治疗的真实世界观察和结局：PERSPECTIVE 研究的国家级亚组分析。
Graefes Arch Clin Exp Ophthalmol. 2024 Oct;262(10):3261-3271. doi: 10.1007/s00417-024-06414-z. Epub 2024 May 9.
5
Assessment of the efficacy of 0.1% cyclosporine A cationic emulsion in the treatment of dry eye disease during COVID-19 pandemic.评估 0.1%环孢素 A 阳离子乳剂治疗 COVID-19 大流行期间干眼症的疗效。
Rom J Ophthalmol. 2023 Apr-Jun;67(2):164-168. doi: 10.22336/rjo.2023.28.
6
Efficacy and safety of topical cyclosporine 0.1% in moderate-to-severe dry eye disease refractory to topical cyclosporine 0.05% regimen.0.1%局部用环孢素治疗对0.05%局部用环孢素方案难治的中重度干眼症的疗效和安全性。
Taiwan J Ophthalmol. 2023 Mar 13;13(1):68-74. doi: 10.4103/tjo.TJO-D-22-00140. eCollection 2023 Jan-Mar.
7
Management of inflammation in dry eye disease: Recommendations from a European panel of experts.干眼疾病炎症管理：欧洲专家小组的建议。
Eur J Ophthalmol. 2023 May;33(3):1294-1307. doi: 10.1177/11206721221141481. Epub 2022 Dec 5.
8
Real-World Effectiveness, Tolerability and Safety of Cyclosporine A 0.1% Cationic Emulsion in Severe Keratitis and Dry Eye Treatment.0.1%环孢素A阳离子乳液在重度角膜炎和干眼症治疗中的真实世界有效性、耐受性及安全性
Ophthalmol Ther. 2022 Jun;11(3):1101-1117. doi: 10.1007/s40123-022-00487-x. Epub 2022 Mar 17.
本文引用的文献
1
Efficacy and safety of 0.1% ciclosporin A cationic emulsion in dry eye disease: a pooled analysis of two double-masked, randomised, vehicle-controlled phase III clinical studies.0.1%环孢素 A 阳离子乳剂治疗干眼的疗效和安全性：两项双盲、随机、对照的 III 期临床研究的汇总分析。
Br J Ophthalmol. 2019 Jan;103(1):125-131. doi: 10.1136/bjophthalmol-2017-311801. Epub 2018 Mar 15.
2
TFOS DEWS II Management and Therapy Report.TFOS DEWS II 管理和治疗报告。
Ocul Surf. 2017 Jul;15(3):575-628. doi: 10.1016/j.jtos.2017.05.006. Epub 2017 Jul 20.
3
One-Year Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in the Treatment of Severe Dry Eye Disease.0.1%环孢素A阳离子乳剂治疗重度干眼病的一年疗效与安全性
Eur J Ophthalmol. 2017 Nov 8;27(6):678-685. doi: 10.5301/ejo.5001002.
4
A randomized study of the efficacy and safety of 0.1% cyclosporine A cationic emulsion in treatment of moderate to severe dry eye.一项关于0.1%环孢素A阳离子乳剂治疗中重度干眼症疗效和安全性的随机研究。
Eur J Ophthalmol. 2017 Aug 30;27(5):520-530. doi: 10.5301/EJO.5000952. Epub 2017 Mar 21.
5
Efficacy and safety of 0.1% cyclosporine A cationic emulsion in the treatment of severe dry eye disease: a multicenter randomized trial.0.1%环孢素A阳离子乳剂治疗重度干眼病的疗效和安全性：一项多中心随机试验
Eur J Ophthalmol. 2016 Jun 10;26(4):287-96. doi: 10.5301/ejo.5000779. Epub 2016 Apr 7.
6
Effect of loteprednol etabonate 0.5% on initiation of dry eye treatment with topical cyclosporine 0.05%.0.5%氯替泼诺依碳酸酯对0.05%局部用环孢素起始干眼治疗的影响。
Eye Contact Lens. 2014 Sep;40(5):289-96. doi: 10.1097/ICL.0000000000000049.
7
Successfully improving ocular drug delivery using the cationic nanoemulsion, novasorb.使用阳离子纳米乳剂Novasorb成功改善眼部药物递送。
J Drug Deliv. 2012;2012:604204. doi: 10.1155/2012/604204. Epub 2012 Feb 27.
Zotero 插件